Sensitivity, specificity, and accuracy of a liquid biopsy approach utilizing molecular amplification pools

Circulating cell-free DNA (cfDNA) has the potential to be a specific biomarker for the therapeutic management of lung cancer patients. Here, a new sequencing error-reduction method based on molecular amplification pools (MAPs) was utilized to analyze cfDNA in lung cancer patients. We determined the...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia, Jessica, Kamps-Hughes, Nick, Geiguer, Florence, Couraud, Sébastien, Sarver, Brice, Payen, Léa, Ionescu-Zanetti, Cristian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144209/
https://www.ncbi.nlm.nih.gov/pubmed/34031447
http://dx.doi.org/10.1038/s41598-021-89592-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144209/
https://www.ncbi.nlm.nih.gov/pubmed/34031447
http://dx.doi.org/10.1038/s41598-021-89592-8

Ejemplares similares